What is the 13F Pro Quality Score for RDNT?

13F Pro ranks RadNet, Inc. (RDNT) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View RDNT's current score at https://13fpro.ai/research/RDNT (free sign-up required for the full ranking).

Which hedge funds own the most RDNT stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of RDNT include BlackRock,, RTW INVESTMENTS,, VANGUARD PORTFOLIO MANAGEMENT. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/research/RDNT as soon as new 13F filings post.

Where does 13F Pro source RDNT data?

All RadNet, Inc. fundamentals and ownership data come directly from SEC EDGAR. RadNet, Inc. files with the SEC under CIK 790526. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is RDNT in?

RadNet, Inc. (RDNT) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is RDNT research updated on 13F Pro?

RDNT's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

RadNet, Inc.(RDNT)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 790526 RDNT stock profile & AI dashboard →

13F Pro Quality Score

51.4/100

Rank #1,399 of 2,879 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

70.9/100

Profitability

27.0/100

Balance Sheet

30.9/100

Earnings Quality

30.0/100

Free Cash Flow

71.6/100

Institutional Flow

74.7/100

Revenue Scale

62.9/100

Dilution Risk

36.1/100

RDNT Stock Analysis & AI Quality Score

AI stock analysis and institutional research for RadNet, Inc. (RDNT), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores RDNT at 51.4/100 on a 32-signal composite quality model, placing it at rank #1,399 of 2,879 stocks — the top half of the AI-ranked universe. Areas of concern include profitability (27.0) and earnings quality (30.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 36.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), RadNet, Inc. reports quarterly revenue of $575.6M, net income of $-33.5M, free cash flow of $79.0M. Top institutional holders of RDNT by reported 13-F value include BlackRock,, RTW INVESTMENTS,, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. RDNT trades on the Nasdaq exchange and files with the SEC under CIK 790526. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate RDNT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for RadNet, Inc. directly from SEC EDGAR. RadNet, Inc.'s 13F Pro composite quality score has ranged between 8 and 70 since 2021, currently 51.4 — an improving long-term trajectory across 56 quarterly and live scoring snapshots.

✦

Fun facts about RadNet, Inc.

Quirks, history, and lore behind RDNT — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. healthcare services company · mid-cap · listed on Nasdaq · headquartered in Los Angeles, California.
2
The Numbers
Operates over 400 outpatient imaging centers across the U.S., making it one of the largest networks of its kind in the country.
3
The History
Founded in 1981, it spent decades quietly buying up independent imaging clinics, turning a fragmented mom-and-pop industry into a scaled national platform.
4
The Secret
It's betting big on AI-powered diagnostics to read scans faster and catch what human eyes miss — quietly becoming a tech-forward healthcare company in a lab coat.
5
The Lore
Its home turf of Southern California remains its largest market, and it has expanded into New York, New Jersey, and Maryland — basically wherever bodies need scanning.
6
The Giveaway
If you've ever had an MRI, CT scan, or X-ray at a standalone imaging center in a U.S. strip mall, there's a decent chance the sign outside said RadNet.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$575.6M

Net Income

Q1 2026

$-33.5M

Free Cash Flow

Q1 2026

$79.0M

ROIC

Q1 2026

-1.1%

D/E Ratio

Q1 2026

1.03

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+26.2% YoY

$2.04BFY 2025

FY21 $1.32BFY22 $1.43BFY23 $1.62BFY25 $2.04B

Net Income

-713.6% YoY

$-18.7MFY 2025

FY21 $24.7MFY22 $10.7MFY23 $3.0MFY25 $-18.7M

Operating Income

-37.2% YoY

$62.0MFY 2025

FY21 $82.6MFY22 $46.4MFY23 $98.7MFY25 $62.0M

EPS (Diluted)

-600.0% YoY

$-0.25FY 2025

FY21 $0.46FY22 $0.17FY23 $0.05FY25 $-0.25

Total Assets

+39.7% YoY

$3.76BFY 2025

FY21 $2.06BFY22 $2.43BFY23 $2.69BFY25 $3.76B

Total Debt

+31.5% YoY

$1.12BFY 2025

FY21 $765.8MFY22 $863.9MFY23 $848.0MFY25 $1.12B

Op. Cash Flow

+35.3% YoY

$298.8MFY 2025

FY21 $149.5MFY22 $146.4MFY23 $220.9MFY25 $298.8M

Metric	FY 2025	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Revenue	$2.04B +26.2%	$1.62B +13.0%	$1.43B +8.7%	$1.32B +22.7%	$1.07B -7.1%	$1.15B
Net Income	$-18.7M -713.6%	$3.0M -71.5%	$10.7M -56.9%	$24.7M +266.6%	$-14.8M -200.6%	$14.8M
Operating Income	$62.0M -37.2%	$98.7M +112.9%	$46.4M -43.8%	$82.6M +131.3%	$35.7M -48.9%	$69.9M
EPS (Diluted)	$-0.25 -600.0%	$0.05 -70.6%	$0.17 -63.0%	$0.46 +258.6%	$-0.29 -200.0%	$0.29
Total Assets	$3.76B +39.7%	$2.69B +10.5%	$2.43B +18.2%	$2.06B +15.2%	$1.79B +8.5%	$1.65B
Total Debt	$1.12B +31.5%	$848.0M -1.8%	$863.9M +12.8%	$765.8M +9.1%	$702.2M -0.5%	$706.0M
Operating Cash Flow	$298.8M +35.3%	$220.9M +50.8%	$146.4M -2.1%	$149.5M -36.0%	$233.8M +124.1%	$104.3M

AI Insight: RDNT Financial Trends

RadNet's revenue surged 25% from Q2 2024 to Q1 2026, but recurring Q1 operating losses and persistently thin net income signal structural seasonality masking underlying profitability concerns.

• Revenue grew consistently from $460M in Q2 2024 to $576M in Q1 2026, a ~25% increase over eight quarters.

• Operating income turned sharply negative in both Q1 2025 (-$24M) and Q1 2026 (-$24M), revealing a recurring seasonal earnings trough.

• Equity strengthened from $881M in Q2 2024 to $1,081M in Q1 2026, partly reflecting retained earnings and likely equity issuance.

• Total debt rose to $1,128M in Q2 2025 before modestly declining to $1,113M in Q1 2026, leaving leverage elevated.

⚠ Q1 net losses of -$38M (2025) and -$33M (2026) suggest seasonal cash burns — monitor whether operating CF holds or deteriorates.

⚠ Debt jumped $93M between Q1 2025 and Q2 2025 — track acquisition activity and whether leverage begins a sustained decline.

⚠ Operating CF improved to $79M in Q1 2026 vs. $41M in Q1 2025 — if sustained, this divergence from net losses is encouraging.

AI Insight: RDNT Ratio Trends

RadNet's Q1 2026 operating margin collapsed to -4.2%, mirroring Q1 2025's seasonal loss and signaling a persistent first-quarter structural drag.

• Operating margin swings sharply negative each Q1: -5.1% in Q1 2025 and -4.2% in Q1 2026, versus +5–7% in intervening quarters.

• Leverage improved modestly; D/E declined from 1.19 in Q2 2024 to 1.02 in Q4 2025 and 1.03 in Q1 2026.

• TTM operating margin stands at just 2.9%, dragged down by two consecutive Q1 loss quarters within the trailing period.

⚠ Q1 seasonality is worsening: Q1 2026 NPM of -5.8% compares unfavorably to Q1 2025's -8.1% — both deep losses with no recovery offset yet.

⚠ ROIC turned negative at -4.4% in Q1 2026; sustained recovery into mid-single digits in Q2–Q3 2026 is critical to validate the trend.

⚠ D/E holding near 1.03 — watch whether Q1 cash burn pressures leverage back toward 2024 highs above 1.15.

Get alerted when RDNT's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for RadNet, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of RDNT

BlackRock, Inc.
$560.9M10,035,734 sh
RTW INVESTMENTS, LP
$239.5M4,285,000 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$217.9M3,899,127 sh
BECK MACK & OLIVER LLC
$177.0M3,166,192 sh
VANGUARD CAPITAL MANAGEMENT LLC
$173.9M3,111,012 sh
STATE STREET CORP
$148.2M2,651,598 sh
GEODE CAPITAL MANAGEMENT, LLC
$96.4M1,723,607 sh
Invesco Ltd.
$91.3M1,633,495 sh
JB CAPITAL PARTNERS LP
$79.6M1,424,061 sh
Hood River Capital Management LLC
$78.9M1,411,497 sh

Fund	Value	Shares
BlackRock, Inc.	$560.9M	10,035,734
RTW INVESTMENTS, LP	$239.5M	4,285,000
VANGUARD PORTFOLIO MANAGEMENT LLC	$217.9M	3,899,127
BECK MACK & OLIVER LLC	$177.0M	3,166,192
VANGUARD CAPITAL MANAGEMENT LLC	$173.9M	3,111,012
STATE STREET CORP	$148.2M	2,651,598
GEODE CAPITAL MANAGEMENT, LLC	$96.4M	1,723,607
Invesco Ltd.	$91.3M	1,633,495
JB CAPITAL PARTNERS LP	$79.6M	1,424,061
Hood River Capital Management LLC	$78.9M	1,411,497

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put RDNT on your watchlist

Track score changes the day RadNet, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is RDNT a good stock to buy?

13F Pro's AI-powered analysis of RadNet, Inc. (RDNT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for RDNT are available on the RDNT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own RDNT?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling RDNT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of RadNet, Inc.'s investment landscape.